Sara shares her transformative experience with psychedelic-assisted therapy and emphasizes its potential to revolutionize treatment for trauma, particularly PTSD. With promising FDA approvals on the horizon for MDMA and the widespread availability of ketamine, she advocates for making these therapies accessible to all, especially through group treatment approaches. Additionally, she highlights the importance of respecting indigenous practices in the evolving landscape of psychedelic therapy.
